IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET

Abstract

The current approaches to the drug pricing commonly used worldwide allow for incorporating the therapeutic value of the drug into its consumer price. The drug pricing system existing in the Russian Federation restricts the availability of highly effective innovative drugs and leads to unnecessary expenses of the national budget. In this article, we propose a novel concept of price control relevant to Russia, which is based on the approaches used elsewhere.

Keywords

• price regulation
• methods of pricing
• innovation index
• value-oriented pricing